COVID-19 Hot/Red Sites

Across Derbyshire COVID-19 Hot/Red sites are being developed to assess patients with suspected coronavirus symptoms.

Hot/Red site principles:

A ‘HOT/RED’ site can be defined as a location(s) where patients can be seen who:

  • cannot be excluded from having COVID-19 and have respiratory symptoms

  • all patients need to be triaged by a senior GP at their practice; and 111 can redirect back to their own practice to make an appointment at the Hub - no 111 directly bookable appointments

  • do not need to be admitted directly, but clinician assess that they require further clinical assessment; these patients may call the practices after being directed to by 111 after assessment through this service

  • no patients in the shielded group can be seen here

  • patients must be ambulatory and full attention to strict infection control measures must be taken

Responsibility for meeting the standards lies with the site owner through the responsible person. If the site is owned by a ‘body corporate’ the directors must assure themselves that the standards are being met.

The Medicines Management Framework has been compiled to support the development of the Primary Care COVID-19 Hot/Red Site Protocol.

 Framework  Last Updated  Review Date
 Derby and Derbyshire Medicines Management COVID-19 Red Site Framework  April 2020  March 2022

Local resources

COVID-19 Hot Site Service Operating Procedures

This document is a guide for COVID hot sites, accepting that individual sites will apply their locally agreed specific principles. This document uses the most up to date information available for sharing with clinicians, but it must be noted that it is not an evidence based protocol, and therefore clinicians should use their clinical judgement when seeing patients and their skills/experience.

DDCCG COVID-19 Red Home Visiting and Hub Service Specification

The key aim of the service is to deliver home visits by suitably qualified and equipped clinicians to patients deemed urgent and truly housebound, meaning they cannot attend the Red Hub Clinic.

DDCCG Remote Vital Signs Service - Process

Remote Vital Signs Service supports remote consultations in Primary Care. This is a service to support clinical decision making during the COVID-19 pandemic 2020. The aim is to manage patients at home (including care homes) where possible, reducing direct patient contact and thereby infection risk, and unnecessary hospital admission.

Guidance for the redeployment of EPS at Red Hub Sites TPP and EMIS

This document outlines deployment process based on current understanding for TPP and EMIS Electronic Prescription Service (EPS).

Red Hub Patient Specific Template

Red Hub Patient Specific Template COVID-19 Assessment Form

Risk Assessment Template

Health care professionals are responsible for the prescribing and dispensing/supply and/or administration of medicines the process needs to be underpinned by a risk assessment. There also needs to be an audit trail and clear processes in place to limit errors.

Safe use of medicines in a community setting checklist

Checklist for the safe use of medicines in a community setting

Stock Transfer Template

For stock transferring to a different destination

Medication Received Record

To record medication received on-site

Balance Stock Check Template

To record a weekly stock balance of medication and to audit expiry date checking

Medication Disposal Record

To record transfer of medication for disposal

Storage Area Temperature Record

To record daily room/storage area temperature readings where medication is being kept

Red Hub guide - Diabetes

Red Hub guide when seeing patients with diabetes (info for PCN CDs)

Red Hub printables - Diabetes

Printable protocols to attach to blood glucose and ketone meters


National guidance

Patient Specific Directions

Specialised Pharmacy Services (SPS) Q&A on Patient Specific Directions (PSD). It includes the definition, examples of PSDs, what is not a PSD and commonly asked questions.

RPS guidance on ethical, professional decision making in the COVID-19 pandemic

Produced by the Royal Pharmaceutical Society (RPS) provides guidance to pharmacists and pharmacy technicians to assist with difficult decisions being made in the exceptional circumstance presented by COVID-19. It contains guidance on structured decision making and more specific examples relevant to the current pandemic.

Guidance on Prescribing, Dispensing, Supplying and Administration of Medicines

The Royal College of Nursing (RCN), Royal Pharmaceutical Society (RPS) and Specialist Pharmacy Service (SPS) position statement on prescribing, dispensing, supplying and administration of medicines

Professional guidance on the safe and secure handling of medicines

Royal Pharmaceutical Society (RPS) professional guidance covering areas such as the storage, transportation and disposal of medicines

Professional guidance on the administration of medicines in healthcare settings

Co-produced by the Royal Pharmaceutical Society (RPS) and Royal College of Nursing (RCN) provides principle-based guidance to ensure the safe administration of medicines by healthcare professionals

Advisory guidance on administration of medicines by nursing associates

Health Education England (HEE) guidance covering education and training, safety critical medications, administration of medicines via alternative routes, governance and assurance

Healthcare regulators

Care Quality Commissioning (CQC)

CQC is the independent regulator of health and adult social care in England. Their role is to make sure health and social care services provide people with safe, effective, compassionate, high-quality care and to encourage care services to improve

Medicines and Healthcare Products Regulatory Agency (MHRA)

MHRA regulates medicines, medical devices and blood components for transfusion in the UK. Recognised globally as an authority in its field, the agency plays a leading role in protecting and improving public health and supports innovation through scientific research and development